Women taking estrogen had fewer signs of Alzheimer’s in their brains
Women who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs of Alzheimer’s disease in their brains, according to a large study of more than 21,000 participants. Hormone therapy use was linked to 39% lower odds of a dement
This study's findings are certainly intriguing, and they add to the ongoing conversation about the potential benefits of hormone therapy for women's health. The fact that estrogen-only therapy was associated with a lower risk of dementia and Alzheimer's disease suggests that estrogen may have a protective effect on the brain. This is particularly relevant for women who are experiencing menopause, as they may be at increased risk for cognitive decline.
It's essential to note, however, that this study's results are based on a large observational dataset, and more research is needed to confirm these findings. Additionally, hormone therapy is not without risks, and women should consult with their healthcare providers before starting any new treatment. The wellness community will be watching to see how these findings are translated into practical recommendations for women's health.
In the meantime, women and their healthcare providers may want to consider the potential benefits and risks of hormone therapy as part of a comprehensive approach to brain health. As the researchers continue to analyze the data and explore the underlying mechanisms, we can expect to learn more about the relationship between estrogen, hormone therapy, and cognitive decline. What's next to watch is how this study's results influence the development of new treatments and guidelines for women's health and brain wellness.
Originally reported by sciencedaily.com. WellnessNews adds analysis for health & wellness readers.